Zimo Liu

SAHA (vorinostat) facilitates functional polymer-based gene transfection via upregulation of ROS and synergizes with TRAIL gene delivery for cancer therapy

Zhuxian Zhou, Xiangrui Liu, Min Zheng, 2018, Journal of drug targeting.

Nanoprodrug ratiometrically integrating autophagy inhibitor and genotoxic agent for treatment of triple-negative breast cancer.

Zhuxian Zhou, Xiangrui Liu, Jianbin Tang, 2022, Biomaterials.

Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy

Xiangrui Liu, Youqing Shen, Xuefei Zhou, 2022, Acta pharmaceutica Sinica. B.

Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer.

Xiangrui Liu, Youqing Shen, Huan Meng, 2021, Biomaterials.

Selenopeptide Nanomedicine Activates Natural Killer Cells for Enhanced Tumor Chemoimmunotherapy

Yuliang Zhao, Mandi Wang, Lei Wang, 2022, Advanced materials.

Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells.

Xiangrui Liu, Xuefei Zhou, Quan Zhou, 2023, Journal of controlled release : official journal of the Controlled Release Society.

RNA-based modulation of macrophage-mediated efferocytosis potentiates antitumor immunity in colorectal cancer.

Xuefei Zhou, Aifu Lin, Tianhua Zhou, 2023, Journal of controlled release : official journal of the Controlled Release Society.